Source-grounded facts extracted from Dror Ortho-Design, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dror Ortho-Design, Inc. issued convertible note to purchasers signatory to the Securities Purchase Agreement for an aggregate principal amount of $275,000.
“the Company agreed to sell to the Purchasers in a private placement (the “Private Placement”), Debentures (the “Debentures”) in an aggregate principal amount of $275,000”
Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with each of the purchasers signatory thereto (effective 2026-04-28).
“On April 28, 2026, Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).”
Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with each of the purchasers signatory thereto valued at $200,000 (effective 2026-02-26).
“On February 26, 2026, Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).”
Dror Ortho-Design, Inc. issued warrant to accredited investors.
“the Company agreed to issue (A) subject to the consummation of a public offering by the Company of its securities (the "Public Offering"), warrants to purchase up to a number of shares of common stock (the "Purchase Warrants")”
Dror Ortho-Design, Inc. issued convertible note to accredited investors for aggregate principal amount of $250,000.
“the Company agreed to sell to the Purchasers in a private placement (the "Private Placement"), Debentures (the "Debentures") in an aggregate principal amount of $250,000 due February 28, 2026”
Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with each of the purchasers signatory thereto valued at $250,000 (effective 2025-12-30).
“On December 30, 2025, Dror Ortho-Design, Inc. (the “Company”), a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).”
Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with the Purchasers valued at $200,000 (effective 2025-12-02).
“On December 2, 2025, Dror Ortho-Design, Inc. (the “Company”), a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers signatory thereto (each, a “Purchaser” and, collectively the “Purchasers”).”
Dror Ortho-Design, Inc. issued convertible note to accredited investors for aggregate principal amount of $200,000.
“Agreement, the Company agreed to sell to the Purchasers in a private placement (the “Private Placement”), Debentures (the “Debentures”) in an aggregate principal amount of $200,000 due February 2, 2026 (the “Maturity Date”). In addition, pursuant to the Purchase Agreement the Company agreed to issue (A) subject to the consummation of a public offering by”
Dror Ortho-Design, Inc.: Increased authorized shares of common stock from 500,000,000 to 3,254,475,740 and corresponding change to authorized capital stock (effective 2024-01-04).
“At the Annual Meeting, the Company’s stockholders also approved the adoption of the Company’s Amended and Restated Certificate of Incorporation (the “Restated Charter”) and an amendment to the Restated Charter to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) from 500,000,000 to 3,254,475,740 and to make a corresponding change to the number of authorized shares of capital stock (the “Authorized Share Increase Amendment”).”
Dror Ortho-Design, Inc. shareholders approved Approval of the 2023 Plan..
“Approval of the 2023 Plan. For Against Abstain Broker non-votes 816,367,167 1,504,770 - -”
Dror Ortho-Design, Inc. shareholders approved Approval of the adoption of an amendment to the Restated Charter to effect a reverse stock split of the Company’s Common Stock, at a ratio in the range of 1-for-1,000 to 1-for-100,000 (the “Reverse Stock Split”), with the exact exchange ratio and timing to be determined at the discretion of the Boar.
“Approval of the adoption of an amendment to the Restated Charter to effect a reverse stock split of the Company’s Common Stock, at a ratio in the range of 1-for-1,000 to 1-for-100,000 (the “Reverse Stock Split”), with the exact exchange ratio and timing to be determined at the discretion of the Board but prior to the one-year anniversary of the date on which the Reverse Stock Split is approved by the Company’s stockholders at the Annual Meeting and to be set forth in a public announcement. For Against Abstain 812,503,694 5,368,243 -”
Dror Ortho-Design, Inc. shareholders approved Approval of the Authorized Share Increase Amendment..
“Common Stock For Against Abstain 277,114,834 6,862,270 -”
Dror Ortho-Design, Inc. shareholders approved Approval of the adoption of the Restated Charter..
“Approval of the adoption of the Restated Charter. For Against Abstain 817,871,937 - -”
Dror Ortho-Design, Inc. shareholders approved Election of the five directors named in the Proxy Statement to the Board to serve until the annual meeting of stockholders in 2024 or until each one’s respective successor has been duly elected and qualified..
“Eliyahu (Lee) Haddad 817,866,937 5,000 - - Moshe Shvets 817,866,937 5,000 - - Chaim Hurvitz 817,866,937 5,000 - - Chaim Ravad 510,991,546 306,880,391 - - Yehuda Englander 817,866,937 5,000 - -”
Dror Ortho-Design, Inc.: Corrected typographical error in Certificate of Designations of Series A Convertible Preferred Stock to grant voting rights to holders, aligning with the Amended and Restated Certificate of Incorporation (effective 2023-11-08).
“On November 8, 2023, Dror Ortho-Design, Inc. (the “Company”) filed a certificate of correction (the “Certificate of Correction”) to the Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware.”
Dror Ortho-Design, Inc.: Board adopted new Bylaws effective immediately, replacing existing bylaws with revisions to meeting procedures, quorum, proxy rules, director/officer provisions, and indemnification (effective 2023-10-24).
“On October 24, 2023, the Board adopted the Bylaws, effective immediately.”
Dror Ortho-Design, Inc. engaged Barzily And Co., CPA’s as its auditor.
“On October 24, 2023, the Board engaged Barzily And Co., CPA’s (“Barzily”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, effective immediately.”
Dror Ortho-Design, Inc. dismissed Sadler, Gibb & Associates, LLC as its auditor.
“On October 18, 2023, the Board of Directors (the “Board”) of Dror Ortho-Design, Inc. (the “Company”) dismissed Sadler, Gibb & Associates, LLC (“Sadler”) as the Company’s independent registered public accounting firm, effective immediately.”
Dror Ortho-Design, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of $200,000 (effective 2023-08-14).
“On August 14, 2023, Dror Ortho-Design, Inc. (the “"Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain investors”
Dror Ortho-Design, Inc.: Company changed its name to Dror Ortho-Design, Inc. via an amended charter (effective 2023-08-14).
“On August 14, 2023, the Company filed the Amended Charter with the Secretary of State of the State of Delaware. The key amendment included in the Amended Charter was the change to the name of the Company to “Dror Ortho-Design, Inc.””
Dror Ortho-Design, Inc. completed an acquisition involving shareholders of Private Dror (closed 2023-08-14).
“on August 14, 2023, the shareholders of Private Dror transferred all of their ordinary shares in Private Dror to the Company in exchange for 7,576,999 newly issued shares of Series A Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), of the Company and 106,782,187 shares of common stock, par value $0.0001 per share (the “Common Stock”). As a result of these share exchanges, Private Dror became a wholly owned subsidiary of the Company.”
Dror Ortho-Design, Inc. entered into Share Exchange Agreement with Dror Ortho-Design Ltd. valued at Share exchange for 1,048,585,364 shares of Preferred Stock; assumption of Dror's outstanding share o (effective 2023-07-05).
“On July 5, 2023, Novint Technologies, Inc. (the “ Company ”) entered into a Share Exchange Agreement (the “ Exchange Agreement ”) by and among the Company, Dror Ortho-Design Ltd., a company incorporated under the laws of the State of Israel (“ Dror ”) and the shareholders of Dror.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.